ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,624, issued on June 30, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).
"Antibody that binds to VEGF and PDGF-B" was invented by Roland Beckmann (Singapore), Kristian Hobolt Jensen (Vienna), Hubert Kettenberger (Munich) and Janina Speck (Penzberg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-VEGF/anti-PDGF-B antibodies and methods of using the same."
The patent was filed on Sept. 28, 2022, under Application No. 17/936,073.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%...